INKT
Price
$7.07
Change
-$0.31 (-4.20%)
Updated
May 8, 12:31 PM (EDT)
Capitalization
29.27M
VRDN
Price
$12.78
Change
+$0.49 (+3.99%)
Updated
May 8 closing price
Capitalization
1B
89 days until earnings call
Ad is loading...

INKT vs VRDN

Header iconINKT vs VRDN Comparison
Open Charts INKT vs VRDNBanner chart's image
MiNK Therapeutics
Price$7.07
Change-$0.31 (-4.20%)
Volume$516
Capitalization29.27M
Viridian Therapeutics
Price$12.78
Change+$0.49 (+3.99%)
Volume$1.05M
Capitalization1B
INKT vs VRDN Comparison Chart
Loading...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INKT vs. VRDN commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INKT is a StrongBuy and VRDN is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (INKT: $6.92 vs. VRDN: $12.78)
Brand notoriety: INKT and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INKT: 93% vs. VRDN: 113%
Market capitalization -- INKT: $29.27M vs. VRDN: $1B
INKT [@Biotechnology] is valued at $29.27M. VRDN’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INKT’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • INKT’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, VRDN is a better buy in the long-term than INKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INKT’s TA Score shows that 3 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • INKT’s TA Score: 3 bullish, 5 bearish.
  • VRDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VRDN is a better buy in the short-term than INKT.

Price Growth

INKT (@Biotechnology) experienced а -6.48% price change this week, while VRDN (@Biotechnology) price change was -6.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

INKT is expected to report earnings on May 07, 2025.

VRDN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1B) has a higher market cap than INKT($29.3M). INKT YTD gains are higher at: 5.898 vs. VRDN (-33.333). INKT has higher annual earnings (EBITDA): -14.07M vs. VRDN (-266.36M). VRDN has more cash in the bank: 718M vs. INKT (393K). INKT has less debt than VRDN: INKT (4.61M) vs VRDN (21.1M). VRDN has higher revenues than INKT: VRDN (302K) vs INKT (0).
INKTVRDNINKT / VRDN
Capitalization29.3M1B3%
EBITDA-14.07M-266.36M5%
Gain YTD5.898-33.333-18%
P/E RatioN/AN/A-
Revenue0302K-
Total Cash393K718M0%
Total Debt4.61M21.1M22%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INKTVRDN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APPS3.610.52
+16.83%
Digital Turbine
ARGX622.937.82
+1.27%
argenx SE
BTCS1.670.01
+0.60%
BTCS
IDA116.33-0.34
-0.29%
IDACORP
KRP11.88-0.15
-1.25%
Kimbell Royalty Partners LP

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
N/A
RAIN - INKT
43%
Loosely correlated
+17.17%
LPTX - INKT
43%
Loosely correlated
+1.94%
ABCZF - INKT
33%
Loosely correlated
N/A
TERN - INKT
30%
Poorly correlated
+0.50%
SABS - INKT
30%
Poorly correlated
+1.20%
More